emocha and miDiagnostics collaborate to achieve more comprehensive mobile testing

Post Date: 
Baltimore-based tech startup emocha is collaborating with miDIAGNOSTICS in order to combine hardware and software to augment current medical tests for patients and health care providers. Emocha is a Johns Hopkins startup spinout and the end goal is to utilize each company’s strengths to bring test results and diagnosing to mobile devices.
The Johns Hopkins Center for Clinical Global Health Education developed emocha in 2014 to create a wide-ranging mobile platform with “disease-agnostic” apps. Their OMS app allows at-risk populations to self-monitor epidemic outbreak symptoms and provides guidance on the course of action, and miLINC app links patients to proper care via email, text and in-app modules.